Monday, April 26, 2010 11:59:15 AM
Written by Staff and Wire Reports
Monday, 26 April 2010 06:45
A senior POSC official has confirmed to BioMedReports that a "very important and positive development regarding a partnership whose details can not yet be discussed" will be presented at the announced press conference. "Obviously, the company has gone through great expense and effort to organize this important event, and we would not be undertaking such tasks if the announcements we have have to make weren't important to our company and it's shareholders," said the official.
The following was released by the company via press release this morning:
Positron Corporation (OTCBB:POSC), a molecular imaging solutions company focused on Nuclear Cardiology, today announced that its CEO Patrick Rooney and senior executives will present at the NASDAQ MarketSite in Times Square, New York City, NY.
They will discuss new initiatives and recent highlights including their Frost & Sullivan 2010 North American New Product Innovation Award for their Attrius PET Scanner.
When: May 5, 2010, 1:00 pm EDT
Where: NASDAQ MarketSite, 4 Times Square, New York, NY
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM